Risk of bias tool for impact evaluations | |||
---|---|---|---|
Description | Question | Coding | |
ID | Study | ||
Unique study identification #Paper | Surname/year of first author of paper for effect size data extraction | For example, PES001Open answer | |
Research methods—study design and risk of bias | Design type | What type of study design is used? |
1 = Randomised controlled trial (RCT) (random assignment to households/individuals) 2 = Cluster‐RCT 3 = RDD (quasiexperiment with discontinuity assignment) 4 = CBA (comparison group with baseline and endline data collection) 5 = Panel data, but no baseline 6 = Comparison group with endline data only 7 = Natural experiment 8 = Other |
Methods used for analysis | Which methods are used to control for selection bias and confounding? |
1 = PSM 2 = Covariate matching 3 = DID 4 = IV‐regression 5 = Heckman selection model 6 = Fixed effects regression 7 = Other regression 8 = Randomised study |
|
Design and analysis method description | Briefly describe the study design and analysis method undertaken by the authors | Open answer | |
Mechanism of assignment | 1: Mechanism of assignment: was the allocation or identification mechanism able to control for selection bias? | 1 = Yes, 2 = No, 8 = Unclear | |
Mechanism of assignment | Justification for coding decision (include a brief summary of justification for rating, mentioning your response to all sub questions, cite relevant pages) | Open answer | |
Group equivalence | 2: Group equivalence: was the method of analysis executed adequately to ensure comparability of groups throughout the study and prevent confounding? | 1 = Yes, 2 = No, 8 = Unclear | |
Group equivalence | Justification for coding decision (include a brief summary of justification for rating, mentioning your response to all sub questions, cite relevant pages) | Open answer | |
Spill‐overs, cross‐overs and contamination | 3: Spill‐overs, cross‐overs and contamination: was the study adequately protected against spill‐overs, cross‐overs and contamination? | 1 = Yes, 2 = No, 8 = Unclear | |
Spill‐overs, cross‐overs and contamination | Justification for coding decision (include a brief summary of justification for rating, mentioning your response to all sub questions, cite relevant pages) | Open answer | |
Outcome reporting | 4: Outcome reporting: was the study free from selective outcome reporting? | 1 = Yes, 2 = No, 8 = Unclear | |
Outcome reporting | Justification for coding decision (include a brief summary of justification for rating, mentioning your response to all sub questions, cite relevant pages) | Open answer | |
Analysis reporting | 5: Analysis reporting: was the study free from selective analysis reporting? | 1 = Yes, 2 = No, 8 = Unclear | |
Analysis reporting | Justification for coding decision (include a brief summary of justification for rating, mentioning your response to all sub questions, cite relevant pages) | Open answer | |
Performance bias | 6: Performance bias: was the process of being observed free from motivation bias? | 1 = Yes, 2 = No, 8 = Unclear | |
Performance bias | Justification for coding decision (include a brief summary of justification for rating, mentioning your response to all sub questions, cite relevant pages) | Open answer | |
Other bias | 7: Other risks of bias: Is the study free from other sources of bias? | 1 = Yes, 2 = No, 8 = Unclear | |
Other bias | Justification for coding decision (include a brief summary of justification for rating, mentioning your response to all sub questions, cite relevant pages) | Open answer | |
Type of comparison group |
1 = No intervention (business as usual) 2 = Other intervention 3 = Placebo control 4 = Pipeline (wait‐list) control |
||
Other intervention differentially received by comparison group | Describe any nonenvironmental comparison group intervention received which treatment group does not? | Open answer | |
Unit of analysis | Are there any unit of analysis errors? (e.g., the unit of analysis is different from the unit of treatement allocation and authors do not correct for these unit of analysis differences)? | 1 = Yes, 2 = No, 8 = Not clear, 9 = N/A | |
Blinded participants | Blinding of participants? | 1 = Yes, 2 = No, 9 = N/A | |
Blinded observers | Blinding of outcome assessors? | 1 = Yes, 2 = No, 9 = N/A | |
Blinded analysts | Blinding of data analysts | 1 = Yes, 2 = No, 9 = N/A | |
Method used to blind | Describe method(s) used to blind | Open answer (including describe method of placebo control) |